First-in-Human Trial of VBC101 in Participants With Advanced Solid Tumor Malignancies
Clinical trial NCT07136779 · RECRUITING
Trial details
- NCT number
- NCT07136779
- Sponsor
- VelaVigo Bio Inc
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-23
- Primary completion
- 2027-07-01
- Enrollment
- 310
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.